title: [Experimental identification of drugs with function of targeted up-regulating ID4 expression: bioinformatics-based prediction and preliminary validation].
abstract: OBJECTIVE
  To screen new candidate molecular-targeted anti-leukemia compounds with potential functions of targeted up-regulating ID4 gene expression.
  
  
  METHODS
  Promoter region of ID4 gene including the upstream - 3000 bp sequence of transcriptional start site and message RNA sequence were fished out. Online promoter analysis tools of TESS and Genomax were used to search possible sequence of transcriptional start site and message RNA sequence were fished out. Online promoter analysis tools of TESS and Genomax were used to search possible cis-acting structure from human transcription factor database. The activity of related drugs with potential effects upon ID4 gene expression was analyzed using SAGE database. GEO database was applied to search the gene expression profiling regulated by ID4 gene. Finally, similar analysis between gene expression profiling by ID4 and genome-wide profiling regulated by 163 known drugs or active compounds was manipulated to screen the drugs and candidate compounds with similar gene expression profiling with ID4 gene. MOLT4 cell line was treated with the above candidate active compounds to investigate the ID4 gene expression by RT-PCR assay.
  
  
  RESULTS
  ID4 gene had a type II promoter with a typical TATA box in upstream -45 bp of transcription start site. The 1300 bp-length promoter of ID4 gene contained a few cis-acting structures classified into two function types, i. e. positive regulatory type, including transcription factors Spl and c-Myb, cAMP, glucocorticoid receptor (GR) and estrogen receptor (ER), and negative regulatory type, including Wilms tumor-1 (WT1) and early growth response-2 (EGR2). The similarity of gene expression profiling was identified between cAMP and ID4 gene. ID4 gene expression was induced in MOLT4 cell line after treatment with calcium dibutyryladenosine cyclophosphate at the concentration of 0.1 mmol/L.
  
  
  CONCLUSIONS
  The comprehensive bioinformatic analysis, based upon the combination of regulatory sequence prediction of promoter, similarity analysis of gene expression profiling and literature review, can be considered as a practical tool in screening the candidate drugs with the activity of targeted regulating functional genes. Calcium dibutyryladenosine cyclophosphate can induce ID4 gene expression in leukemic cells.
authors: Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China.
authors: Bo
authors: B
authors: Yang
authors: Xue-Chun
authors: XC
authors: Lu
authors: Li-Hong
authors: LH
authors: Liu
authors: Hong-Li
authors: HL
authors: Zhu
authors: Xiao-Hua
authors: XH
authors: Chi
authors: Shan-Qian
authors: SQ
authors: Yao
authors: Fang-Ding
authors: FD
authors: Lou
authors: Li
authors: L
authors: Yu
mesh_terms: D045744:Cell Line, Tumor; D019295:Computational Biology; D006801:Humans; D051796:Inhibitor of Differentiation Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D012045:Regulatory Sequences, Nucleic Acid; D017422:Sequence Analysis, DNA; D015854:Up-Regulation
chemical_list: C490128:ID4 protein, human; D051796:Inhibitor of Differentiation Proteins; D012333:RNA, Messenger